HBIO - Harvard Bioscience, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
113,335
113,335
118,904
102,100
116,176
Cost of Revenue
52,516
52,516
51,252
44,059
51,854
Gross Profit
60,819
60,819
67,652
58,041
64,322
Operating Expenses
Research Development
12,329
12,329
10,799
8,685
10,715
Selling General and Administrative
49,534
49,534
48,947
43,425
46,024
Total Operating Expenses
67,985
67,985
65,586
57,820
62,485
Operating Income or Loss
-7,166
-7,166
2,066
221
1,837
Interest Expense
2,548
2,246
1,540
4,831
5,410
Total Other Income/Expenses Net
535
233
-666
-2,682
-1,929
Income Before Tax
-9,179
-9,179
-140
-7,292
-5,502
Income Tax Expense
337
337
148
518
-815
Income from Continuing Operations
-9,516
-9,516
-288
-7,810
-4,687
Net Income
-9,516
-9,516
-288
-7,810
-4,687
Net Income available to common shareholders
-9,516
-9,516
-288
-7,810
-4,687
Basic EPS
-
-
-0.01
-0.20
-0.12
Diluted EPS
-
-
-0.01
-0.20
-0.12
Basic Average Shares
-
-
40,343
38,640
37,814
Diluted Average Shares
-
-
40,343
38,640
37,814
EBITDA
-
-811
7,240
3,249
5,654